Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY12 | Q9H244 | 2/20 | 0.65 |
| ▸ | DNPH1 | O43598 | 8/20 | 0.63 |
| ▸ | TAS1R3 | Q7RTX0 | 2/20 | 0.59 |
| ▸ | TAS1R1 | Q7RTX1 | 2/20 | 0.59 |
| ▸ | P2RY2 | P41231 | 2/20 | 0.59 |
| ▸ | P2RY1 | P47900 | 2/20 | 0.59 |
| ▸ | TRPM2 | O94759 | 2/20 | 0.59 |
| ▸ | PRKAB2 | O43741 | 1/20 | 0.59 |
| ▸ | LDHA | P00338 | 1/20 | 0.59 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.59 |
| ▸ | FBP1 | P09467 | 1/20 | 0.59 |
| ▸ | SRC | P12931 | 1/20 | 0.59 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.59 |
| ▸ | PRKAG1 | P54619 | 1/20 | 0.59 |
| ▸ | PRKAA2 | P54646 | 1/20 | 0.59 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.59 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.59 |
| ▸ | PRKAA1 | Q13131 | 1/20 | 0.59 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4125974 | 0.93 | P2RY12 (0.72) | P2RY12DNPH1TAS1R3TAS1R1P2RY2 | |
| SCHEMBL5545796 | 0.88 | P2RY12 (0.69) | P2RY12DNPH1TAS1R3TAS1R1P2RY2 | |
| SCHEMBL855679 | 0.88 | SLC29A1 (0.61) | ADORA1PRKAG1PRKAA1PRKAB1 | |
| SCHEMBL3193571 | 0.87 | P2RY12 (0.68) | P2RY12DNPH1TAS1R3TAS1R1P2RY2 | |
| SCHEMBL1933421 | 0.87 | P2RY12 (0.67) | P2RY12DNPH1TAS1R3TAS1R1P2RY2 | |
| SCHEMBL4997219 | 0.87 | P2RY12 (0.69) | P2RY12DNPH1TAS1R3TAS1R1P2RY2 | |
| Adenosine Phosphate SCHEMBL15670947 | 0.86 | P2RY1 (0.73) | DNPH1TAS1R3TAS1R1P2RY2P2RY1 | |
| SCHEMBL2990779 | 0.86 | P2RY12 (0.66) | P2RY12DNPH1TAS1R3TAS1R1P2RY2 | |
| SCHEMBL8916648 | 0.86 | P2RY12 (0.70) | P2RY12DNPH1TAS1R3TAS1R1P2RY2 | |
| SCHEMBL3898255 | 0.85 | P2RY12 (0.65) | P2RY12DNPH1TAS1R3TAS1R1P2RY2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 84 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3681504-B1 | METHODS OF DETECTION USING X-RAY FLUORESCENCE | ICAGEN INC (US) | 2023-08-23 | — | — | EP | disclosed |
| US-11573224-B2 | Methods of detection using X-ray fluorescence | ICAGEN, LLC (US) | 2023-02-07 | — | — | US | disclosed |
| US-20210254056-A1 | IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS | CAMP4 THERAPEUTICS CORPORATION | 2021-08-19 | — | — | US | disclosed |
| US-10877035-B2 | Advanced drug development and manufacturing | ICAGEN, LLC (US) | 2020-12-29 | — | — | US | disclosed |
| US-10781437-B2 | D-stereospecific aminoacyl-tRNA synthetase and method of producing D-stereospecific aminoacyl-tRNA synthetase | BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY (US) | 2020-09-22 | — | — | US | disclosed |
| US-20200278346-A1 | METHODS OF DETECTION USING X-RAY FLUORESCENCE | ADJACENT ACQUISITION CO., LLC | 2020-09-03 | — | — | US | disclosed |
| EP-3681504-A1 | METHODS OF DETECTION USING X-RAY FLUORESCENCE | Icagen, Inc. (US) | 2020-07-22 | — | — | EP | disclosed |
| WO-2019055754-A1 | METHODS OF DETECTION USING X-RAY FLUORESCENCE | ICAGEN, INC. (US) | 2019-03-21 | — | — | WO | disclosed |
| WO-2018204764-A1 | IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS | CAMP4 THERAPEUTICS CORPORATION (US) | 2018-11-08 | — | — | WO | disclosed |
| US-9943577-B2 | Aminoacyl tRNA synthetases for modulating inflammation | ATYR PHARMA, INC. (US) | 2018-04-17 | — | — | US | disclosed |
| US-6617114-B1 | Screening for ligand which inhibits the binding of a target protein to a binding partner ligand; steroid receptors; peptides of given sequence | KARO BIO AB (SE) | 2003-09-09 | — | — | US | disclosed |
| EP-1274834-A1 | HUMAN AMINOACYL-tRNA SYNTHETASE POLYPEPTIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS | The Scripps Research Institute (US) | 2003-01-15 | — | — | EP | disclosed |
| EP-1272506-A1 | HUMAN AMINOACYL-TRNA SYNTHETASE POLYPEPTIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS | The Scripps Research Institute (US) | 2003-01-08 | — | — | EP | disclosed |
| WO-2001075078-A1 | HUMAN AMINOACYL-tRNA SYNTHETASE POLYPEPTIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS | THE SCRIPPS RESEARCH INSTITUTE (US) | 2001-10-11 | — | — | WO | disclosed |
| WO-2001074841-A1 | HUMAN AMINOACYL-TRNA SYNTHETASE POLYPEPTIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS | THE SCRIPPS RESEARCH INSTITUTE (US) | 2001-10-11 | — | — | WO | disclosed |
| EP-0937253-A1 | IDENTIFICATION OF DRUGS USING COMPLEMENTARY COMBINATORIAL LIBRARIES | Novalon Pharmaceutical Corporation (US) | 1999-08-25 | — | — | EP | disclosed |
| US-5912140-A | ISOLATED NUCLEIC ACID WHICH CODES A FUNCTIONAL PORTION OF A LYSYL-TRNA SYNTHETASE; HAVING CATALYTIC ACITIVITY AND BINDING FUNCTION; DRUG SCREENING FOR AIDS THERAPY | CUBIST PHARMACEUTICALS, INC. (US) | 1999-06-15 | — | — | US | disclosed |
| US-5871987-A | Candida tyrosyl-tRNA synthetase proteins, nucleic acids and strains comprising same | CUBIST PHARMACEUTICALS, INC. (US) | 1999-02-16 | — | — | US | disclosed |
| WO-1998019162-A9 | IDENTIFICATION OF DRUGS USING COMPLEMENTARY COMBINATORIAL LIBRARIES | — | 1998-07-09 | — | — | WO | disclosed |
| WO-1998019162-A1 | IDENTIFICATION OF DRUGS USING COMPLEMENTARY COMBINATORIAL LIBRARIES | NOVALON PHARMACEUTICAL CORPORATION (US) | 1998-05-07 | — | — | WO | disclosed |